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Abstract: Open-Access Mega-Journals (OAMJs) are a relatively new and increasingly important
publishing phenomenon. The journal Medicine is in the unique position of having transitioned in
2014 from being a ‘traditional’ highly-selective journal to the OAMJ model. This study compares
the bibliometric profile of the journal Medicine before and after its transition to the OAMJ model.
Three standard modes of bibliometric analysis are employed, based on data from Web of Science:
journal output volume, author characteristics, and citation analysis. The journal’s article output is
seen to have grown hugely since its conversion to an OAMJ, a rise driven in large part by authors
from China. Articles published since 2015 have fewer citations, and are cited by lower impact
journals than articles published before the OAMJ transition. The adoption of the OAMJ model has
completely changed the bibliometric profile of the journal, raising questions about the impact of
OAMJ peer-review practices. In many respects, the post-2014 version of Medicine is best viewed as a
new journal rather than a continuation of the original title.
Keywords: mega-journal; open access; bibliometrics
1. Introduction
The journal Medicine is the only journal to date to have moved from being a conventional journal
to being a so-called ‘mega-journal’. Analysing the effects of this transition has the potential to cast light
on the current scholarly communications market in general and on the ‘mega-journals’ phenomenon
in particular. This paper provides a bibliometric study of the effects of the transition of Medicine.
Published by Wolters Kluwer, Medicine was launched in 1922 as a selective, subscription journal
covering all areas of medicine. Since the 1960s, the journal has published between 30 and 50 articles
per year across six issues. In 2012, however, the publisher announced that it would be converting
the journal to the mega-journal model. Duncan MacRae, the journal’s Senior Publisher, described the
rationale behind the transition:
“The journal did not have the support of a society, and that lack of a built-in base of authors
and readers limited its ability to compete with other general medicine journals. At the
same time, Wolters Kluwer was looking to produce a broad open access publication, and
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converting an established title was considered a more attractive option than launching an
entirely new title” [1].
The mega-journal iteration of Medicine, which began publishing mid-way through 2014, covers
45 distinct medical sub-disciplines, and lists 845 editorial board members. It operates a Gold Open
Access (OA) publishing model in which authors are required to pay an Article Processing Charge (APC)
of $1400, and journal content is then made freely available to any reader on publication. The journal
now publishes a new issue each week, and employs a peer-review policy that focuses solely on an
article’s ‘scientific soundness’:
“The goal of Medicine’s review process is to establish an article’s technical, scientific and
ethical validity. Novelty and potential for impact are not to be considered when assessing a
manuscript or providing an editorial recommendation” [2].
This was controversial, with some seeing it as signalling a decline in quality [3]. However,
‘soundness-only’ peer review is a key feature of open-access mega-journals (OAMJs) in general, which
are a relatively recent feature in the scholarly communication landscape.
The term ‘mega-journal’ appears to have been coined to describe PLOS ONE, which launched
in 2006 and has been followed, particularly since 2011, by a number of other ‘PLOS ONE-like’
journals, including Scientific Reports, PeerJ, BMJ Open and Royal Society Open Science [4]. As with
any emergent term, opinions vary as to the precise definition, but recent work suggests that
mega-journals have four key characteristics: high publishing volume, a broad subject scope, a Gold
OA business model, and a peer-review policy that seeks only to evaluate objectively the technical
or scientific soundness of an article, rather than its potential significance or impact [5]. This last
characteristic—‘objective’ peer review—undoubtedly represents the most disruptive innovation, since
it challenges the long-established practice of journals selecting content based on perceived novelty or
importance. Advocates and publishers of OAMJs argue that their approach essentially democratises
knowledge by facilitating the publication of all scientifically-sound papers and allowing the academic
community as a whole, rather than a small group of editors and reviewers, to determine which are
most important or useful [6]. In contrast, critics of the model perceive OAMJs as low quality ‘dumping
grounds’ for articles rejected from traditional journals, suggesting that the pre-publication filtering of
content by editors and reviewers serves a vital purpose within scholarly discourse [7].
As the only journal to have transitioned from a selective to a mega-journal model, Medicine
offers a unique opportunity to analyse the impact of the new model. A recent review of the
literature relating to OAMJs has revealed that relatively few peer-reviewed articles have addressed
the mega-journal phenomenon [4]. Of these, Björk provides an overview, including OAMJ publishing
volume, subject scope, and peer review policies [5]. He also identifies a larger number of secondary
OAMJ characteristics, including fast publication times, the incorporation of altmetrics in discovery
platforms, moderate APCs, and the use of academic (rather than in-house) editors. Solomon surveyed
authors published in four mega-journals (BMJ Open, PeerJ, PLOS ONE and Sage Open), finding that
just over half of all papers (52%) had previously been submitted to other journals [8]. This is more
than double the rate of 25% found by Calcagno et al. in their study of 923 biosciences journals [9].
Authors were found to view the quality of the journal and the speed of publication as the two most
important factors influencing submission to a mega-journal, with the journal’s impact factor also being
a significant factor for PLOS ONE authors.
There are also a number of bibliometric studies focusing on OAMJs. Fein presents a study of
PLOS ONE which analyses the volume and type of journal output, as well as citation rates [10]. Burns bases
his analysis of PeerJ on a sample of 49 articles, investigating author demographics, usage data and citation
rates [11]. Bjork and Catani investigate the effect of OAMJ peer review policies, comparing citation
distributions of several OAMJs with more traditional selective journals [12]. They found little difference
between the two groups. Finally a broad study by the authors of this paper presents bibliometric profiles
for 11 mega-journals, with analyses focused on journal output, subject scope, author demographics
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and citation rates [13]. While this study includes some data relating to Medicine, the scope of the paper
precludes any detailed analysis of the journal’s transition to OAMJ status.
2. Methods
The aim of this study is to provide a comparative bibliometric analysis of Medicine before and
after its transition from a traditional selective journal to an OAMJ, in order both to reveal potentially
significant changes to the character of the journal, and potentially better understand the impact of the
OAMJ model. Bibliometric studies of single journals are relatively common—reviews by Tiew [14] and
by Anyi et al. [15] report around 200 such studies—and this paper utilises three frequently employed
modes of analysis: journal output, author characteristics (particularly nationality and institutional
affiliation), and citation analysis. All data were obtained using the Web of Science core collection
database (WoS), which was found to have slightly greater coverage of Medicine than Scopus (both in
terms of years and number of articles indexed). For all analyses presented below, ‘Publication Name’
searches were used to retrieve all items published in Medicine (and other journals where appropriate),
and refinements by date used to limit results to relevant time periods. Only items classified by WoS
as ‘Articles’ or ‘Reviews’ were considered, with both types of paper referred to as ‘articles’ in the
remainder of this study. Where appropriate, analyses were also conducted on two additional journals
in order to provide some context to the Medicine results: BMJ Open, the largest other mega-journal
covering solely medicine; and PLOS Medicine, a selective OA journal.
3. Results
3.1. Journal Output
Table 1 shows the number of articles published in Medicine each year since 2004, along with
the percentage increase or decrease in output from the previous year. In the eight years prior to
the mega-journal transition (2006–2013) the journal published a total of 299 articles, an average of
37.4 per year, and indeed the journal had been publishing at this level since the 1960s. Although
output fluctuated somewhat, there appears to be little evidence suggesting a deliberate attempt to
grow the journal, since each year of growth is followed by a reduction in size the following year.
In the first six months of 2014, a further 23 articles were published, at which point the journal began
operating as a mega-journal. 292 articles were published in the remaining six months of the year,
almost as many as in the previous eight years combined, while 2015 saw a further dramatic rise to
almost 2000 articles. Although the rate of growth slowed somewhat in 2016, the journal still published
no less than 3124 articles. It is helpful to provide some context for these figures: Medicine’s output in
2016 makes it the 12th largest journal of the almost 12,000 indexed in WoS, and the 6th largest title
covering medical disciplines.
Table 1. Annual output of Medicine since 2004, and % change from previous year.
Year Output % Change
2004 30 −25.0
2005 36 +20.0
2006 32 −11.1
2007 38 +18.8
2008 36 −5.3
2009 42 +16.7
2010 38 −9.5
2011 48 +26.3
2012 35 −27.1
2013 30 −14.3
2014 315 +950.0
2015 1989 +531.4
2016 3124 +57.1
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It is also instructive to compare this output with that of other mega-journals. While PLOS ONE
remained the largest journal in the world (2016 = 21,011 articles), Medicine is already larger than all but
one other OAMJ—Nature’s Scientific Reports (2016 = 19,999).
3.2. Author Characteristics
Analysis of author characteristics focuses on author nationalities and institutional affiliations.
In both cases a comparison is made between the ten years prior to the mega-journal launch (2004–2013),
and the two years after the transition (2015–2016). A ten year period was used to ensure sufficient
articles were included in the analysis. 2014 was excluded from the analysis since the journal published
articles evaluated under both traditional and OAMJ peer review policies for parts of this year;
mega-journal articles were first published in July, but it was not clear when the final article reviewed
under the traditional model was published.
Table 2 shows the ten most common author nationalities for the 365 articles published in Medicine
between 2004 and 2013, along with the number and percentage of articles with at least one author
from each country. Author nationalities are derived from the location of their affiliated institution.
For papers with multiple authors, data relating to each author are included. The results show that
during the earlier period the journal published articles predominantly from authors based in the
USA, France and Spain. In total 278 of the 365 articles (76.2%) have an author from one of these
three countries. This stands in stark contrast to the figures for 2015–2016. China emerges as the
most prolific contributor, and 2633 of 3517 articles (74.9%) have at least one author from one of four
Asian countries: China, Taiwan, South Korea and Japan. It should also be noted that while French,
Spanish and American authors each provide proportionally fewer articles, their actual contribution
has increased considerably. The USA, for example, provides an author for on average 13.1 articles per
year between 2004 and 2013, a figure that rises to 213.3 for the post-mega-journal period.
Table 2. Medicine 2004–2013 and 2015–2016—Ten most common author nationalities and % of articles
with at least one author from that country.
Medicine 2004–2013 (365 Articles) Medicine 2015–2016 (5113 Articles)
Country Articles % of All Articles Country Articles % of All Articles
1 USA 131 35.9 China 2207 43.2
2 France 92 25.2 Taiwan 830 16.2
3 Spain 69 18.9 South Korea 616 12.1
4 Taiwan 15 4.1 USA 484 9.5
5 Israel 13 3.6 Japan 223 4.4
6 Japan 11 3.0 Italy 206 4.0
7 Canada 10 2.7 France 178 3.5
8 UK 10 2.7 Germany 111 2.2
9 Italy 10 2.7 Spain 108 2.1
10 China 10 2.7 UK 111 2.0
Table 3 presents the 10 most common author affiliations for articles published in the same two
periods. Prior to the mega-journal transition the most prolific institutions were European (particularly
French) or American, with the top five contributing institutions providing almost a third (32.9%) of
all papers published by the journal. The most commonly found contributors to the mega-journal, in
contrast, are all Asian institutions. The top five institutions are all Taiwanese, and four of the remaining
five Chinese (the exception is Yonsei University, South Korea). These top contributors, while providing
many more articles in total than the top-producing institutions pre-OAMJ, are responsible for a lower
proportion of total journal output, the top five institutions contributing to 11.8% of all articles published
in this period. Table 3 also shows the number of articles published by each institution in the other
time period. Here we note that all of the most prolific contributors in the 2003–2014 period have
also published papers in the mega-journal iteration of the journal. Indeed, given the much shorter
lifespan of the mega-journal, these institutions have published proportionally more frequently in the
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mega-journal than they did in the decade prior to the transition. This contrasts strongly with the most
common OAMJ contributing institutions, only half of whom had authored any articles at all in the
2004–2013 period.
Table 3. Medicine 2004–2013 and 2015–2016—Ten most common author institutional affiliations and %
of articles with at least one author from that institution.
Medicine 2004–2013 (365 Articles)
Institution Articles % of All Articles 2015–2016 Articles
1 Assistance Publique Hôpitaux Paris (APHP) 68 18.6 96
2 University of Barcelona 33 9.0 30
3 Université Sorbonne Paris Cité (USPC) 30 8.2 52
4 Hôpital Universitaire Pitié Salpêtrière (APHP) 26 7.1 29
5 National Institutes of Health (NIH) 22 6.0 12
6 Hospital Clinic de Barcelona 21 5.8 15
7 INSERM 21 5.8 78
8 Johns Hopkins University 20 5.5 29
9 Pierre Marie Curie University Paris 6 18 4.9 32
10 Hôpital Universitaire Saint Louis (APHP) 17 4.7 15
Medicine 2015–2016 (5113 Articles)
Institution Articles % of All Articles 2004–2013 Articles
1 Chang Gung Memorial Hospital 230 4.5 0
2 China Medical University Taiwan 224 4.4 3
3 China Medical University Hospital Taiwan 224 4.4 3
4 Chang Gung University 205 4.0 0
5 National Yang Ming University 165 3.2 1
6 Sun Yat Sen University 156 3.1 1
7 Yonsei University 151 3.0 0
8 National Taiwan University 145 2.8 6
9 Sichuan University 135 2.6 0
10 Peking Union Medical College Hospital 129 2.5 0
3.3. Citation Analysis
Before presenting a more detailed analysis of citation distributions before and after Medicine’s
change to the mega-journal model, it is helpful to review the yearly Journal Impact Factors (JIFs)
awarded to the journal. Table 4 shows these figures, along with the JIFs for BMJ Open and PLOS
Medicine. It is notable that Medicine’s JIF dropped substantially in 2015, the first year to include only
articles published under the mega-journal peer-review policies. 2014 produced Medicine’s highest JIF
of the preceding decade, and ranked the journal 15th of all titles classified as ‘Medicine, General and
Internal’ in WoS. The 2015 figure places the journal 40th in the same list. BMJ Open, which operates an
ostensibly similar peer-review policy, achieved a slightly higher JIF in 2015, and ranks 32nd.
Table 4. Journal Impact Factors for Medicine, PLOS Medicine and BMJ Open.
Year Medicine PLOS Medicine BMJ Open
2004 3.7 n/a n/a
2005 5.1 8.4 n/a
2006 5.2 13.8 n/a
2007 4.7 12.6 n/a
2008 4.3 12.2 n/a
2009 5.1 13.2 n/a
2010 4.3 15.6 n/a
2011 4.4 16.3 n/a
2012 4.2 15.3 1.6
2013 4.9 14.0 2.1
2014 5.7 14.4 2.3
2015 2.1 13.6 2.6
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To compare citation rates and distributions, all articles published in Medicine in 2015 were
identified, and the number of times these papers were cited in articles published before the end
of 2016 was calculated. A similar approach was taken for BMJ Open and PLOS Medicine. Since the
pre-2014 incarnation of Medicine published only ca. 35 articles per year, aggregated data for the three
years prior to the mega-journal transition were used (2011–2013). Only citations made in articles
published before the end of the next calendar year were considered, in order to match the period used
for the other three journals. Table 5 shows the results of this analysis, with a focus on the number of
infrequently cited articles. The pre-mega-journal version of Medicine is found to have a far smaller
proportion of uncited articles, while 78.1% of articles published in 2015 have 2 or fewer citations. It is,
however, notable that the mega-journal version of Medicine has a very similar citation distribution to
that of BMJ Open.
Table 5. Citation data for Medicine (pre- and post-OAMJ transition), BMJ Open and PLOS Medicine.
% of Articles with n Citations
Year Articles Citations by End ofNext Calendar Year
Citations
per Article 0 1 2 ≤2
Medicine (Trad.) 2011–2013 113 623 5.5 11.5 14.2 15.0 40.7
Medicine (OAMJ) 2015 1989 3176 1.6 36.6 26.8 14.8 78.1
BMJ Open 2015 1427 2675 1.9 32.3 25.4 16.2 73.9
PLOS Medicine 2015 97 905 9.3 5.2 9.3 11.3 25.8
Following Björk and Catani [12], cumulative distribution function curves were also plotted for
the four journals, as shown in Figure 1. Once again the citation distributions for the mega-journal
iteration of Medicine and BMJ Open were found to be remarkably similar. The pre-2014 version of
Medicine is shown to have published many more highly cited articles than the two OAMJs, but fewer
than PLOS Medicine.
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Analysis was also carried out on citing journals. Table 6 shows the 20 most common citing journals
for Medicine before and after its change to a mega-journal. Only two journals are common to both lists
(Medicine itself, and PLOS ONE). The proportion of citations to Medicine articles published in Medicine
itself is substantially larger for the mega-journal iteration, accounting for almost a quarter (23.4%) of
all citations. It is noticeable that a high proportion (45%) of the 2004–2013 list relate to rheumatology,
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suggesting that while ostensibly a general medicine title, it may have attracted a high number of
submissions relating to that specialty. It is also interesting to note that the three most commonly found
citing journals for the post-2015 iteration of Medicine are all themselves mega-journals; it is possible
that this may be due to the faster publication speeds often offered by mega-journals.
Table 6. The 20 most common citing journals for Medicine (pre- and post-mega-journal transition).
Titles in bold are common to both lists.
Medicine 2004–2013 (13,107 Total Citations) Medicine 2015–2016 (3,406 Total Citations)
Citing Journal n % Citing Journal n %
1 Medicine 217 1.7 Medicine 579 17.0
2 PLOS ONE 180 1.4 PLOS ONE 133 3.9
3 Clinical and Experimental Rheumatology 176 1.3 Scientific Reports 105 3.1
4 Journal of Rheumatology 167 1.3 Oncotarget 103 3.0
5 Revue de Medecine Interne 158 1.2 World Journal of Gastroenterology 50 1.5
6 Rheumatology 144 1.1 International Journal of Clinical andExperimental Pathology 28 0.8
7 Lupus 132 1.0 International Journal of Clinical andExperimental Medicine 27 0.8
8 Rheumatology International 127 1.0 Tumor Biology 27 0.8
9 Clinical Rheumatology 124 0.9 Oncotargets and Therapy 26 0.8
10 Autoimmunity Reviews 117 0.9 International Journal of Cardiology 22 0.7
11 Clinical Infectious Diseases 117 0.9 International Journal of Molecular Sciences 21 0.6
12 Annals of the Rheumatic Diseases 105 0.8 European Review for Medical andPharmacological Sciences 13 0.4
13 Current Opinion in Rheumatology 97 0.7 Nutrients 12 0.4
14 Internal Medicine 91 0.7 American Journal of Emergency Medicine 11 0.3
15 Presse Medicale 86 0.7 Journal of Surgical Oncology 11 0.3
16 Seminars in Arthritis and Rheumatism 75 0.6 Journal of Thoracic Disease 11 0.3
17 New England Journal of Medicine 73 0.6 Medical Science Monitor 11 0.3
18 Blood 71 0.5 Alimentary Pharmacology Therapeutics 10 0.3
19 Journal of Infection 66 0.5 Biomed Research International 10 0.3
20 Arthritis Care Research 64 0.5 European Journal of Internal Medicine 10 0.3
While the journal’s declining impact factor, and the data presented in Table 5, suggest that recent
Medicine articles are being cited less frequently, they do not indicate whether the characteristics of citing
journals have changed. To explore this, the mean JIF was calculated for the citing journals for each time
period, weighted by the number of citations made in each citing journal. The JIF awarded to the citing
journal for the year of the citation was used, and the results are presented in Table 7. Significant
differences between group means were confirmed by a one-way Welch Anova (F(3,3394) = 83.3,
p < 0.001), with a post-hoc Games-Howell test revealing significant differences between each journal
(p < 0.001). It is apparent that PLOS Medicine’s citations generally come in journals with significantly
higher JIFs than the other titles. While noting the crudity of JIF as a measure, it is interesting to observe
that BMJ Open, while having a similar number of citations to the OAMJ iteration of Medicine (as shown
in Table 5), is shown to publish articles that are cited in journals with higher JIFs than journals citing
Medicine OAMJ articles.
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Table 7. Weighted mean JIFs of citing journals.
Journal Weighted Mean JIF Standard Error of the Mean
Medicine (2004–2013) 3.8 0.05
Medicine (2015–2016) 3.3 0.06
BMJ Open (2015–2016) 4.8 0.13
PLOS Medicine (2015–2016) 7.4 0.32
One final analysis carried out related to articles published by authors affiliated with the most
prolific institutions of the 2004–2013 period. As noted, authors affiliated with all but one of these
institutions have continued to publish in Medicine after its change to an OAMJ, with much greater
frequency. It was considered of interest to compare citation rates for articles by authors at these ten
institutions (i.e., those listed in the top half of Table 3) before and after the OAMJ transition, using the
method described above. The results presented in Table 8 suggest that while volume has increased,
citations have decreased. Over two-thirds (68.2%) of mega-journal articles by these authors were
not cited in the 12–18 months following publication, compared to just 12.5% prior to 2014. Between
2004 and 2013, 8 articles (5.7%) were cited at least 10 times within 18 months of publication, while for
2015–2016 no paper has been cited more than 10 times, and only one article has received more than
5 citations. The weighted mean JIF of the citing journals has also declined significantly (t (4913) = 1.28,
p = 0.007).
Table 8. Citation rates and weighted mean JIFs of citing journals for Medicine articles by authors at the
ten most common 2004–2013 institutions, pre- and post- mega-journal transition.
% of Articles with n Citations
Articles Weighted Mean JIF of Citing Journals SEM 0 1 2 ≤2
2004–2013 141 4.0 0.08 12.5 20.8 15.3 48.6
2015 138 3.1 0.30 68.2 20.2 6.2 94.6
4. Discussion
The results presented show clearly how the shift to a mega-journal model has changed the
bibliometric profile of Medicine. Most striking is the large increase in output, with the journal
now publishing over 3,000 articles per year—an eighty-fold increase on the mean annual output
for the preceding 10 years. While ‘big publishing volume’ is considered a key characteristic of a
mega-journal [5], there remains some disagreement as to what exactly constitutes ‘big’. It is nonetheless
hard to argue that a journal publishing on this scale, which would place it in the top 20 of all journals
by output, and the third largest mega-journal, is not ‘big’. It seems reasonable, therefore, to conclude
that this aspect of the journal’s transition to a mega-journal has been successfully achieved.
Analysis of author characteristics reveals one important factor in this transformation. The vast
increase in publishing volume has clearly been fuelled in large part by an influx of submissions from
Asian authors, particularly Chinese and Taiwanese academics; over half of all papers published have
an author from one of these two countries. This rise in Chinese-authored papers to some extent
matches the broader trend of increased research output from this country, although the extent of 2015
Chinese output in Medicine (42.7%) is much larger than both the equivalent figure across all journals in
WoS (14.6%). It is higher too than the contribution of Chinese authors to PLOS ONE, which Yan and
Rousseau calculate to be 19% [16], and the rate across all other mega-journals (23.1%) [13] . It must also
be noted that analysis of the most common author affiliations reveals that the most prolific contributors
from the pre-OAMJ version of Medicine are still publishing in the journal, in most cases at a much
higher rate. Chinese output can, therefore, be said to be supplementing rather than replacing articles
submitted by authors from European and US institutions.
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This large rise in output can, of course, be partly explained by the change of peer-review policy;
clearly a much higher number of papers are deemed to pass a test of ‘scientific soundness’ than would
be viewed as significant enough to merit publication in the highly selective version of the journal.
Yet this alone is not enough to explain Medicine’s dramatic increase in size. Other OAMJs that cover
medical disciplines, for example PeerJ and BMJ Open, operate almost identical editorial policies yet are
smaller than Medicine. One further explanation lies in Medicine’s impact factor. Until mid-2016, when
the 2015 impact factor was published, the journal could boast a JIF of at least 4.200 for the previous
five years. It seems likely that this legacy Impact Factor, combined with the shift in reviewing policy,
provided a powerful incentive for authors to publish in the journal. Given the generally accepted view
that Chinese authors are particularly sensitive to JIF in selecting journals for publishing their work [17]
(in some cases with financial incentives offered to authors publishing in high Impact Factor titles), this
also goes some way to explaining the demographic profile of the mega-journal.
The fall of Medicine’s Impact Factor is, of course, a result in a decline in citation rates since
the mega-journal transition. The citation analysis presented in this paper reflects this, with a much
higher proportion of post-2015 articles being infrequently cited, or not cited at all within 18 months
of publication. We also find that post-2015 Medicine articles are being cited in journals with a lower
JIF than pre-2014 articles. While it is tempting to draw immediate conclusions about the quality of
articles being published in the mega-journal, it should be noted that other factors may be relevant. It is
possible, for example, that researchers have recognised the change in character of Medicine, and have
as a consequence been less likely to cite articles published in the journal as a whole. More importantly,
the mega-journal model is viewed by many as a mechanism for allowing the dissemination of research
output that might otherwise not be published (commonly cited examples being negative results and
replication studies) [4]. Many such articles are by their nature unlikely to accrue large numbers of
citations, but are still seen by many to contribute to the scientific discourse. Questions of ‘quality’
therefore become more difficult to answer. Ultimately there is a crucial tension at the heart of the
OAMJ approach; the model is by definition counterproductive to maintaining a high impact factor, yet
the JIF remains a powerful factor in attracting high quality submissions. It remains to be seen whether
Medicine is able to maintain its current high output given the much lower 2015 JIF, particularly in
terms of submissions from Chinese authors. Wolters Kluwer must hope that the new OAMJ brand,
and its ability to meet authors’ needs in other ways (for example speed of publication), are robust
enough to mitigate the much lower impact factor. Anecdotal evidence from discussions carried out
as part of a broader mega-journal project suggests that other publishers who do not yet produce a
mega-journal title have viewed the Medicine approach—converting an existing title to the mega-journal
model—as an attractive way to launch an OAMJ. It will be interesting to note the extent to which
Medicine’s evolution serves to support or discourage that view.
The analysis presented in this paper has found the pre- and post-mega-journal iterations of
Medicine to be different in numerous ways: the journal has a different peer-review policy and editorial
board, is vastly different in scale, has different author demographics, and is publishing articles
with different citation rates, which are cited in different journals. Aside from the title and ISSN,
the journal since 2014 is unrecognisable from its previous form. It seems reasonable to conclude,
therefore, that Medicine post-2014 is essentially a different journal. Some might view the rise in
publishing output, combined with falling citation rates, as somehow indicative of a decline in quality
or standards. However, to base such a perception of the journal on raw bibliometric data alone
is to ignore the rationale and ethos behind the OAMJ model. In challenging traditional norms of
scholarly communication mega-journals are attempting to offer a platform for sound research, without
pre-judging the impact of that research. It is important that assessments of the journal are made in that
changing context.
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5. Conclusions
Medicine converted to the mega-journal model in 2014, and has subsequently seen a vast rise
in output combined with a steep fall in citation rates and Impact Factor. The journal’s increase in
output has been driven in large part by Chinese authors, but it is notable that submissions from
European and American authors have also increased. As output has increased, citation rates and,
Impact Factor have declined, a decline that can largely be attributed to the rise in submission rates
which has accompanied the adoption of a ‘soundness-only’ peer-review policy. Ultimately, the view
taken on the value of journals operating such policies will inform any judgement on the role Medicine
now plays in the dissemination of medical research. Mega-journals (of which Medicine is now a
prominent example) are a controversial subject. For some, they represent a paradigm shift towards a
more democratic form of scientific discourse; for others, they are little more than dumping grounds,
cynical money-making operations for publishers willing to compromise editorial standards. Further
research into the mega-journal phenomenon will serve to properly inform this debate. To what extent
are ‘soundness-only’ peer review policies applied consistently within and across mega-journals?
Do publishers view mega-journals primarily as revenue generators, or as instruments of change?
How do authors view OAMJs, and are they influencing publication practices? Will other journals
transition from a traditional to OAMJ model, and will the effects be similar to Medicine? Answering
these questions will not only contextualise quantitative bibliometric studies of mega-journals, but
allow all players to better understand how OAMJs might shape the scholarly communications system.
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